Approval · Notice of Compliance 1732 · 2001
PACIS: Notice of Compliance 1732
Issued July 18, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1732
- Date
- July 18, 2001
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PACIS | 02130947 | Cancelled Post Market |
Medicinal ingredients
- BACILLUS CALMETTE-GUERIN (BCG) SUBSTRAIN MONTREAL 120 MG per VIAL